Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Avalon GloboCare ( (ALBT) ) has provided an update.
On July 14, 2025, Avalon GloboCare Corp. entered into a securities purchase agreement with Brown Stone Capital Ltd., agreeing to issue and sell 121,200 shares of common stock and pre-funded warrants for 354,300 shares, totaling $475,500. The transaction closed on July 17, 2025, with net proceeds of $450,500. The company also agreed to register these shares under the Securities Act of 1933 and granted piggy-back registration rights to the investor. Additionally, on July 15, 2025, Avalon issued 515,109 shares of common stock to a noteholder, bringing its total outstanding shares to 2,954,193.
More about Avalon GloboCare
Avalon GloboCare Corp. is a Delaware-based company operating in the healthcare industry. It focuses on developing and delivering innovative cell-based technologies and therapeutics, with a market focus on advancing cellular medicine and related services.
Average Trading Volume: 249,395
Technical Sentiment Signal: Sell
Current Market Cap: $5.16M
Learn more about ALBT stock on TipRanks’ Stock Analysis page.